Generic Pharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Generic Pharmaceutical stocks.

Generic Pharmaceutical Stocks Recent News

Date Stock Title
Apr 26 CAH 3 Medical Products Stocks Set to Beat This Earnings Season
Apr 26 CAH Cencora (COR) to Report Q2 Earnings: What's in the Cards?
Apr 26 CAH Is Amazon Stock Worth Buying Ahead of Q1 Earnings?
Apr 25 CAH Cardinal Health handed FDA warning for marketing unapproved devices
Apr 25 CAH UPDATE 2-US FDA sends warning letter to Cardinal Health for marketing unapproved devices
Apr 25 CAH Assessing Super Micro Computer (SMCI) Ahead of Q3 Earnings
Apr 25 BHC Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline
Apr 24 CAH What's in Store for NXP Semiconductors' (NXPI) Q1 Earnings?
Apr 24 CAH Rising Demand Likely to Aid GE HealthCare's (GEHC) Q1 Earnings
Apr 24 CAH What's in Store for Charter Communications (CHTR) in Q1 Earnings?
Apr 24 BHC Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
Apr 24 CAH Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Apr 24 CAH Ongoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings
Apr 23 CAH Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know
Apr 23 ABT It’s Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team
Apr 23 CAH What's in Store for STMicroelectronics (STM) in Q1 Earnings?
Apr 23 BHC Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says
Apr 23 CAH Philips' (PHG) Zenition 30 to Boost Image-Guided Surgeries
Apr 23 CAH DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
Apr 23 CAH Is Trending Stock Cardinal Health, Inc. (CAH) a Buy Now?
Generic Pharmaceutical

Generic pharmaceuticals are medications that are produced and distributed without a brand name. They are typically sold at a lower cost than brand-name drugs and are identical in terms of dosage, safety, strength, quality, performance, and intended use. Generic drugs are approved by the U.S. Food and Drug Administration (FDA) and are considered to be as safe and effective as brand-name drugs.

Browse All Tags